Biden’s Pick for CMS Confirmed by Senate, Expected to Push Drug Pricing Legislation

May 26, 2021

The Biden administration’s pick to lead the Centers for Medicare and Medicaid Services (CMS), Chiquita Brooks-LaSure, has been approved by the Senate. She has previously held positions as a healthcare consultant and helped draft the American Care Act. This appointment could signal a push to expand CMS and to regulate drug prices.

“Chiquita Brooks-LaSure, who worked for the Obama administration and helped implement the Affordable Care Act, will oversee the agency’s efforts to expand the healthcare law, set the overall policy agenda for Medicare, Medicaid and the Children’s Health Insurance Program (CHIP)…In her confirmation hearing in April, Brooks-LaSure also mentioned high drug prices, health equity, mental health and substance abuse, and rural health as issues she wants to work on.” Read more here.

(Source: Jessie Hellmann, Modern Healthcare, 5/25/21)

Share This Story!